2023 annual financial data
Seres Therapeutics 2023 Financial results
Direct answer
Revenue was 126.33M USD.
Operating income was -195.1M USD and net income was -113.72M USD.
Operating cash flow was -117.35M USD.
Get free Seres Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 126.33M USD
- Operating income
- -195.1M USD
- Net income
- -113.72M USD
- Operating cash flow
- -117.35M USD
Explore related company data
View all 2023 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Seres Therapeutics financial years